कृपया अन्य खोज का प्रयास करें
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Timothy Richard Scott | 71 | 2017 | Independent Director |
Robert L. Cunningham | 76 | 2017 | Independent Director |
Michael E. Stern | - | 2021 | Member of Medical Advisory Board |
Blake N. Schroeder | 47 | 2022 | Director |
John W. Huemoeller | 69 | 2017 | President, CEO & Director |
Peter M. O’Rourke | 51 | 2020 | Director |
Laura M. Periman | - | 2021 | Member of Medical Advisory Board |
Henry D. Perry | 97 | 2021 | Member of Medical Advisory Board |
Kelly K. Nichols | - | 2021 | Member of Medical Advisory Board |
Joseph Tauber | 67 | 2021 | Chief Medical Officer & Chairman of the Medical Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है